Please assess the completion status of the following clinical trial:

Trial Title: Study Regarding the Clinical Efficacy of Synatura® in Patients With Chronic Bronchitis Type COPD

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Post bronchodilator FEV1/FVC \< 0.7~2. Smoking history of ≥10 packs per year~3. 40 to \<75 years of age~4. Patients with symptoms of chronic bronchitis (in case they have symptoms of cough or sputum over 3 months)~Exclusion Criteria:~1. Patients with acute exacerbation~2. Patients with pneumonia~3. Patients with active tuberculosis~4. Pregnant women~5. Breast-feeding women~6. Patients with fructose intolerance

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Synatura® 15 mL (Type: EXPERIMENTAL): Synatura syrup single arm

Based on this trial design, predict the completion outcome and termination type (if applicable).